Cargando…

Development and Validation of a Composite Programmatic Assessment Tool for HIV Therapy

BACKGROUND: We developed and validated a new and simple metric, the Programmatic Compliance Score (PCS), based on the IAS-USA antiretroviral therapy management guidelines for HIV-infected adults, as a predictor of all-cause mortality, at a program-wide level. We hypothesized that non-compliance woul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lima, Viviane D., Le, Adrian, Nosyk, Bohdan, Barrios, Rolando, Yip, Benita, Hogg, Robert S., Harrigan, P. Richard, Montaner, Julio S. G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3501505/ https://www.ncbi.nlm.nih.gov/pubmed/23185244 http://dx.doi.org/10.1371/journal.pone.0047859

Ejemplares similares

Application and Validation of Case-Finding Algorithms for Identifying Individuals with Human Immunodeficiency Virus from Administrative Data in British Columbia, Canada
por: Nosyk, Bohdan, et al.
Publicado: (2013)

Expansion of HAART Coverage Is Associated with Sustained Decreases in HIV/AIDS Morbidity, Mortality and HIV Transmission: The “HIV Treatment as Prevention” Experience in a Canadian Setting
por: Montaner, Julio S.G., et al.
Publicado: (2014)

Cost-Effectiveness of Antiretroviral Therapy for Multidrug-Resistant HIV: Past, Present, and Future
por: Harris, Marianne, et al.
Publicado: (2012)

A historical review of HIV prevention and care initiatives in British Columbia, Canada: 1996-2015
por: Olding, Michelle, et al.
Publicado: (2017)

Disparities in the Burden of HIV/AIDS in Canada
por: Hogg, Robert S., et al.
Publicado: (2012)

Progress towards the United Nations 90‐90‐90 and 95‐95‐95 targets: the experience in British Columbia, Canada
por: Lima, Viviane D., et al.
Publicado: (2017)

Correction: Disparities in the Burden of HIV/AIDS in Canada
por: Hogg, Robert S., et al.
Publicado: (2018)

The Evolving Landscape of the Economics of HIV Treatment and Prevention
por: Nosyk, Bohdan, et al.
Publicado: (2012)

High Levels of Heterogeneity in the HIV Cascade of Care across Different Population Subgroups in British Columbia, Canada
por: Lourenço, Lillian, et al.
Publicado: (2014)

Physicians’ patient base composition and mortality among people living with HIV who initiated antiretroviral therapy in a universal care setting
por: Allan, Beverly, et al.
Publicado: (2019)

Technical and Regulatory Shortcomings of the TaqMan Version 1 HIV Viral Load Assay
por: Brumme, Chanson J., et al.
Publicado: (2012)

Virologic suppression and mortality of patients who migrate for HIV care in the province of British Columbia, Canada, from 2003 to 2012: a retrospective cohort study
por: Lima, Viviane Dias, et al.
Publicado: (2015)

Emergence of Drug Resistance Is Associated with an Increased Risk of Death among Patients First Starting HAART
por: Hogg, Robert S, et al.
Publicado: (2006)

Geographic variation in the costs of medical care for people living with HIV in British Columbia, Canada
por: Enns, Benjamin, et al.
Publicado: (2019)

Cohort profile: the Comparative Outcomes And Service Utilization Trends (COAST) Study among people living with and without HIV in British Columbia, Canada
por: Eyawo, Oghenowede, et al.
Publicado: (2018)

The impact of HCV co-infection status on healthcare-related utilization among people living with HIV in British Columbia, Canada: a retrospective cohort study
por: Ma, Huiting, et al.
Publicado: (2018)

Estimation of time of HIV seroconversion using a modified CD4 depletion model
por: Lima, Viviane D., et al.
Publicado: (2021)

Trends in reported AIDS defining illnesses (ADIs) among participants in a universal antiretroviral therapy program: an observational study
por: Jafari, Siavash, et al.
Publicado: (2011)

Estimation of measurement error in plasma HIV-1 RNA assays near their limit of quantification
por: Lima, Viviane D., et al.
Publicado: (2017)

Physician's manual reporting underestimates mortality: evidence from a population-based HIV/AIDS treatment program
por: Au-Yeung, Christopher G, et al.
Publicado: (2010)

Cost-Effectiveness of the ‘One4All’ HIV Linkage Intervention in Guangxi Zhuang Autonomous Region, China
por: Zang, Xiao, et al.
Publicado: (2016)

Are Interferon-Free Direct-Acting Antivirals for the Treatment of HCV Enough to Control the Epidemic among People Who Inject Drugs?
por: Lima, Viviane D., et al.
Publicado: (2015)

The temporal relationship between drug supply indicators: an audit of international government surveillance systems
por: Werb, Dan, et al.
Publicado: (2013)

The potential impact of initiating antiretroviral therapy with integrase inhibitors on HIV transmission risk in British Columbia, Canada
por: Zhu, Jielin, et al.
Publicado: (2019)

Changes in lipids over twelve months after initiating protease inhibitor therapy among persons treated for HIV/AIDS
por: Levy, Adrian R, et al.
Publicado: (2005)

Expanding HAART Treatment to All Currently Eligible Individuals under the 2008 IAS-USA Guidelines in British Columbia, Canada
por: Lima, Viviane D., et al.
Publicado: (2010)

Prevalence of Human Immunodeficiency Virus-1 Integrase Strand Transfer Inhibitor Resistance in British Columbia, Canada Between 2009 and 2016: A Longitudinal Analysis
por: Kamelian, Kimia, et al.
Publicado: (2019)

Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study
por: Wood, Evan, et al.
Publicado: (2009)

Validating a Shortened Depression Scale (10 Item CES-D) among HIV-Positive People in British Columbia, Canada
por: Zhang, Wendy, et al.
Publicado: (2012)

“Dynamic Range” of Inferred Phenotypic HIV Drug Resistance Values in Clinical Practice
por: Swenson, Luke C., et al.
Publicado: (2011)

Effects of a switch from tenofovir- to abacavir-based antiretroviral therapy, with or without atazanavir, on renal function
por: Guillemi, Silvia A, et al.
Publicado: (2016)

A province-wide HIV initiative to accelerate initiation of treatment-as-prevention and virologic suppression in British Columbia, Canada: a population-based cohort study
por: Nanditha, Ni Gusti Ayu, et al.
Publicado: (2022)

The impact of scaling-up combination antiretroviral therapy on patterns of mortality among HIV-positive persons in British Columbia, Canada
por: Lima, Viviane Dias, et al.
Publicado: (2015)

Why Maximizing Quality-Adjusted Life Years, rather than Reducing HIV Incidence, Must Remain Our Objective in Addressing the HIV/AIDS Epidemic
por: Nosyk, Bohdan, et al.
Publicado: (2019)

Identification of people with low prevalence diseases in administrative healthcare records: A case study of HIV in British Columbia, Canada
por: Emerson, Scott D., et al.
Publicado: (2023)

Identifying mental health and substance use disorders using emergency department and hospital records: a population-based retrospective cohort study of diagnostic concordance and disease attribution
por: Wang, Linwei, et al.
Publicado: (2019)

Long-term effectiveness of initiating non-nucleoside reverse transcriptase inhibitor- versus ritonavir-boosted protease inhibitor-based antiretroviral therapy: implications for first-line therapy choice in resource-limited settings
por: Lima, Viviane D, et al.
Publicado: (2016)

Process description of developing HIV prevention monitoring indicators for a province-wide pre-exposure prophylaxis (PrEP) program in British Columbia, Canada
por: Munasinghe, Lalani L., et al.
Publicado: (2023)

Missed opportunities for earlier diagnosis of HIV in British Columbia, Canada: A retrospective cohort study
por: Nanditha, Ni Gusti Ayu, et al.
Publicado: (2019)

Healthcare and treatment experiences among people diagnosed with HIV before and after a province-wide treatment as prevention initiative in British Columbia, Canada
por: Tattersall, Tessa, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ijo32fir6vjud9b8rfgek71auu